Adeoye Olukotun

Adeoye Y.
Olukotun is the founder of CR Strategies LLC, founded in 2000, serving as Chief Executive Officer.
Dr. Olukotun was the founder of VIA Pharmaceuticals, Inc., founded in 2004, serving as Chief Medical Officer from 2004 to 2008.
Current jobs include Chief Executive Officer & Trustee at Electrophysiology Research Foundation; Independent Director at Arrowhead Pharmaceuticals, Inc. since 2020; and Independent Director at Tonix Pharmaceuticals Holding Corp.
since 2018.
Former jobs include Chief Executive Officer at ESGL Holdings Ltd.; Chief Executive Officer at Abcentra, Inc. from 2006 to 2013; President & Chief Executive Officer at Epigen Pharmaceuticals, Inc. from 2014 to 2018; Vice Chairman at Cardio Vax LLC from 2012 to 2016; Independent Director at BioClinica, Inc. from 2011 to 2013; Director at Nordion (Canada), Inc. in 2010; Director at Neusentis, Inc.; Director at SemBioSys Genetics, Inc. in 2007; Director at Milestone Pharmaceuticals, Inc.; Director at MDS Nordion, Inc.; Director at BioMedical Systems Corp.; Director at D&R Greenway Land Trust, Inc.; Independent Director at Diadexus, Inc. from 2013 to 2015; Director, Chief Executive & Technology Officer at Genesis Unicorn Capital Corp.; Vice President at Bristol Myers Squibb Co. from 1983 to 1996; Vice President-Medical & Regulatory Affairs at Mallinckrodt, Inc.(Old) from 1996 to 2000; Chief Medical Officer & SVP-Regulatory Affairs at Esperion Therapeutics, Inc. from 2001 to 2004.
Education includes a doctorate from Albert Einstein College of Medicine, Inc. in 1973; graduate degree from Harvard T.H.
Chan School of Public Health in 1983; undergraduate degree from UNC School of Law in 1969.